Zhang Qinpeng, Yin Rui, Guan Guoqiang, Liu Huiyi, Song Guosheng
College of Chemistry and Chemical Engineering, Hunan University, Changsha, Hunan, China.
College of Chemistry, Xiangtan University, Xiangtan, Hunan, China.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Jan-Feb;16(1):e1929. doi: 10.1002/wnan.1929. Epub 2023 Sep 26.
Magnetic resonance imaging (MRI) is a non-invasive, radiation-free imaging technique widely used for disease detection and therapeutic evaluation due to its infinite penetration depth. Magnetic nanoparticles (MNPs) have unique magnetic and physicochemical properties, making them ideal as contrast agents for MRI. However, the in vivo toxicity of MNPs, resulting from metal ion leakage and long-term accumulation in the reticuloendothelial system (RES), limits their clinical application. To overcome these challenges, there is considerable interest in the development of renal-clearable MNPs that can be completely cleared through the kidney, reducing retention time and potential toxic risks. In this review, we provide an overview of recent advancements in the development of renal-clearable MNPs for disease imaging and treatment. We discuss the factors influencing renal clearance, summarize the types of renal-clearable MNPs, their synthesis methods, and biomedical applications. This review aims to offer comprehensive information for the design and clinical translation of renal-clearable MNPs. This article is categorized under: Nanotechnology Approaches to Biology > Nanoscale Systems in Biology Diagnostic Tools > Biosensing.
磁共振成像(MRI)是一种非侵入性、无辐射的成像技术,由于其无限的穿透深度,被广泛用于疾病检测和治疗评估。磁性纳米颗粒(MNPs)具有独特的磁性和物理化学性质,使其成为MRI理想的造影剂。然而,MNPs的体内毒性,源于金属离子泄漏和在网状内皮系统(RES)中的长期积累,限制了它们的临床应用。为了克服这些挑战,人们对开发可通过肾脏完全清除的可肾清除MNPs产生了浓厚兴趣,这可以减少滞留时间和潜在的毒性风险。在这篇综述中,我们概述了用于疾病成像和治疗的可肾清除MNPs开发的最新进展。我们讨论了影响肾脏清除的因素,总结了可肾清除MNPs的类型、它们的合成方法以及生物医学应用。这篇综述旨在为可肾清除MNPs的设计和临床转化提供全面信息。本文分类如下:纳米技术在生物学中的应用>生物学中的纳米级系统;诊断工具>生物传感。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024
Acc Chem Res. 2020-9-15
Nanotechnology. 2019-9-6
Artif Cells Nanomed Biotechnol. 2015-11-19
J Nanobiotechnology. 2024-5-13
Adv Healthc Mater. 2020-5
Adv Healthc Mater. 2017-10-9
Recent Pat Drug Deliv Formul. 2017
Front Chem. 2025-5-26
Beilstein J Nanotechnol. 2024-9-30
Signal Transduct Target Ther. 2024-2-21